Received: 18 June 2026 Accepted: 12 October 2026 Published online: 30 October 2026 UDC: 616.379-008.64-085 DOI: 10.53511/pharmkaz.2026.5.5   Article type: Original Research Article (Clinical Interventional Study)  

Received: 01.07.2026 Accepted: 20.10.2026 Published online: 30.10.2026 UDC: 615.03:616.379-008.64-085-07 SRSTI: 76.31.29, 76.29.37 DOI: 10.53511/pharmkaz.2026.5.4 Article type: Original research article  

Received: 28.05.2026 Accepted: 09.10.2026 Published online: 30.10.2026 UDC: 615.212:615.243 DOI: 10.53511/pharmkaz.2026.5.3 Article type: Scientific review article  

Received: 28.09.2026 Accepted: 19.10.2026 Published online: 30.10.2026 UDC: 616.53-002.25:615.03:579.61 DOI: 10.53511/pharmkaz.2026.5.2 Article type: Original research article (pilot cross-sectional clinical and microbiological study)   CLINICAL PHARMACOLOGICAL PERSPECTIVES OF ADJUVANT PROBIOTIC THERAPY IN ACNE VULGARIS: RESULTS OF A PILOT CULTURE-BASED STUDY OF THE INTESTINAL MICROBIOTA   Dzhumabayeva A.A.¹, Abuova G.N.¹ ¹ South

Received: 20.07.2026 Accepted: 13.10.2026 Published online: 30.10.2026 UDC: 616-08-039.73 DOI: 10.53511/pharmkaz.2026.5.1 Article type: Review article   WARFARIN PHARMACOGENETICS: MODERN INTERNATIONAL PERSONALIZED APPROACHES AND PROSPECTS FOR THEIR IMPLEMENTATION IN THE REPUBLIC OF KAZAKHSTAN   U.E. Imammyrzayev¹, I.K. Tulebayeva¹, B.A. Rakishev², K.E. Kazantayev², S.B. Pazilov³, A.K. Shulgabayev⁴ ¹ Kazakhstan Medical University “KSPH”,